SEO URLwww.firestrike.ai/deals/xposegrafix-mabt-acquisition-2026
acquisitionAnnounced · Feb 3, 2026biotechnologySource · AdvertisementsArticle · Factual
Mabt acquires Xposegrafix
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Xposegrafix
Acquirer
Mabt
Full Acquisition
Status
Announced
Mabt agreed to acquire Xposegrafix. Reported deal value: Undisclosed. Status: Announced. Sector: biotechnology. Target headquarters context: Greece.
This page summarizes publicly available information about the transaction as of 2026-02-03. Figures and status may change as filings and press coverage update.
News in Focus Share to X Mid - Atlantic BioTherapeutics , Inc. today announced the acquisition of XPose Therapeutics , a privately held biotechnology company focused on novel precision oncology therapeutics
Deal timeline
Announced
Feb 3, 2026 · prweb.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biotechnology. Figures and status may change as sources update.
Sources: prweb.com · Primary article · FireStrike proprietary index